← All indications
Low Back Pain
Acute or chronic pain in the lumbar or sacral regions, which may be associated with musculo-ligamentous SPRAINS AND STRAINS; INTERVERTEBRAL DISK DISPLACEMENT; and other conditions.
Drugs by status
Approved for this indication (1)
Phase 4 trials (52)
- diclofenac
- methylprednisolone
- ketoprofen
- urea
- oxycodone
- ibuprofen
- betamethasone
- duloxetine
- cannabidiol
- escitalopram
- glucosamine
- cyanocobalamin
- ketorolac
- platelet-rich plasma
- metamizole
- methocarbamol
- naproxen
- rimabotulinumtoxinB
- platelet rich fibrin
- acetaminophen
- lidocaine
- tizanidine
- levobupivacaine
- celecoxib
- sogyeonghwalhyeol-tang
- buprenorphine
- bupivacaine
- thiocolchicoside
- tramadol
- hydromorphone
- +22 more
Phase 3 trials (36)
- melatonin
- hydrocodone
- human fibrin
- procaine benzylpenicillin
- bone autograft
- carisoprodol
- clobazam
- cyclobenzaprine
- cycloserine
- dulaglutide
- etodolac
- bone marrow derived mesenchymal stem cells
- histamine
- hydrocortisone
- imipramine
- amoxicillin
- tanezumab
- loxoprofen
- meloxicam
- neurotropin
- nicoboxil
- oxycodegol
- vanillylnonamide
- ropivacaine
- caffeine
- fasinumab
- acetylsalicylic acid
- cannabis
- tolterodine
- clonidine
- +6 more
Phase 2 trials (21)
- metformin
- cebranopadol
- fulranumab
- naltrexone
- dronabinol
- mepivacaine
- eperisone
- pamidronate
- propranolol
- tolperisone
- zoledronic acid
- 3-glycosyl-3-odemethylthiocolchicine
- allogeneic adipose derived mesenchymal stem cell
- aripiprazole
- minocycline
- milnacipran
- pregnenolone
- water
- olive
- cayenne pepper
- allogeneic mesenchymal stem cells
Phase 1 trials (6)
Other trials (29)
- nitrous oxide
- propofol
- allogen-li
- amitriptyline
- bee venom
- calcium citrate
- chondroitin
- chuna
- palmitoylethanolamide
- gabapentin
- ethanol
- carbamazepine
- lavender
- myrrha (commiphora myrrha)
- nmp
- magnesium sulfate
- almond
- ircodone
- frankincense
- oxygen
- rose oil
- prednisolone
- venlafaxine
- nortriptyline
- codeine
- extracellular matrix
- aceclofenac
- harpagoside
- zhineng qigong
Organizations
Organization Involved with Phase 4 Indications (80)
- Napo Pharmaceuticals
- Grunenthal
- Merck
- Eli Lilly
- Pfizer
- Sanofi
- Endo Pharmaceuticals
- Mallinckrodt
- Mundipharma
- Targeted Medical Pharma
- Sunovion
- Fundação Educacional Serra dos Órgãos
- National Institutes of Health (NIH)
- Azienda Sanitaria Locale 4, Teramo
- National Center for Complementary and Integrative Health (NCCIH)
- National Institute of General Medical Sciences (NIGMS)
- National Institute on Drug Abuse (NIDA)
- United States Army
- University of Pittsburgh
- Akdeniz University
- Celal Bayar University
- Harvard University
- Duke University
- Gachon University
- University of Washington
- Grupo Rehabilitacion en Salud
- Henry Ford Health System
- Kaiser Permanente
- Kocatepe University
- Northwestern University
- +50 more
Organization Involved with Phase 3 Indications (88)
- Abbott
- AbbVie
- Meda
- Regeneron
- Ache Laboratorios Farmaceuticos S.A.
- Horizon Pharma
- Eisai
- Takeda
- Labopharm
- Cephalon
- Bausch Health Companies
- Shionogi
- Alza
- Ipsen
- Purdue Pharmaceuticals
- Bayer
- BioDelivery Sciences International
- Braeburn Pharmaceuticals
- DOV Pharmaceutical, Inc.
- Eurofarma Laboratorios S.A.
- Farmoquimica S.A.
- Nektar Therapeutics
- Spinal Restoration, Inc.
- Teva
- VanWorld Pharmaceutical (Rugao) Company Limited
- Boehringer Ingelheim
- Collegium Pharmaceutical, Inc.
- Navipharm Corporation
- Zogenix, Inc.
- United States Air Force
- +58 more
Organization Involved with Phase 2 Indications (43)
- Forest Laboratories
- Astellas
- Novartis
- Allodynic Therapeutics, LLC
- CHABiotech CO., Ltd
- Indena S.p.A
- Red de Terapia Celular
- Teikoku Pharma USA, Inc.
- Daewon Pharmaceutical Co., Ltd.
- Durect
- Frontier Biotechnologies Co., Ltd.
- Stayble Therapeutics
- National Institute of Neurological Disorders and Stroke (NINDS)
- Smigel, Liza, M.D.
- Ardabil University of Medical Sciences
- Azad University
- Hospital de Egas Moniz
- Inje University
- Kyung Hee University
- McGill University
- Rijnstate Hospital
- University of Oulu
- Yale University
- University of California, San Diego
- Icahn School of Medicine at Mount Sinai
- Istanbul Medipol University
- University of Indonesia
- Wilhelminenspital der Stadt Wien
- Abecma
- Hanmi Pharmaceutical
- +13 more
Organization Involved with Phase 1 Indications (7)
Organization Involved with Other Experimental Indications (34)
- Hamilton Health Sciences Corporation
- Ataturk University
- Case Western Reserve University
- Chang Gung University
- Dartmouth University
- Hillel Yaffe Medical Center
- Johns Hopkins University
- Korea Institute of Oriental Medicine
- Postgraduate Institute of Medical Education and Research
- Universidad Autónoma Benito Juárez de Oaxaca
- University of Seville
- University of Southern California
- University of Thessaly
- University of Toronto
- University of Alberta
- University of Athens
- Wake Forest University
- West Virginia University
- Assiut University
- Istanbul University
- Stony Brook University
- Zhejiang University
- Bone and Joint Clinic of Baton Rouge
- Regenexx
- Smolensk State Medical Academy
- Catholic University of Korea
- Second Military Medical University
- Ludwig Maximilians University
- Soonchunhyang University
- State University of New York, Syracuse
- +4 more